The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones,
salts, and prodrugs thereof, to processes for their preparation, and to
pharmaceutical compositions comprising the same. More particularly, the
invention relates to the use of those compounds in the prevention and
treatment of obesity and related syndromes.